Such genetic alternation as alternative splicing, TP53 mutation, regulation of non-coding RNA, and DNA methylation served as critical players in progression of HCC (Cancer Genome Atlas Research Network, 2017; Xu et al., 2017; Kahles et al., 2018; Wong et al., 2018). The gene discussed is TP53; the disease is hepatocellular carcinoma.